Name: Alexion Pharmaceuticals, Inc. (ALXN) Fundamental & Financial Data
Creator: Stocktwits

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX shares are experiencing significant volatility following a high-revenue earnings report that was overshadowed by massive capital expenditures and investor anxiety regarding an upcoming influx of insider shares. The community remains deeply divided, with bulls pointing to the company's long-term dominance in space and AI infrastructure, while vocal bears are heavily shorting the stock, citing extreme valuations and imminent dilution from the unlocking of nearly one billion insider shares.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as investors react to a flurry of major catalysts, including an imminent satellite launch and technical workshops with Meta regarding WhatsApp integration. The community is actively discussing the company's progress in expanding its constellation and regulatory milestones in Japan, which are fueling bullish sentiment as it positions itself as an independent satellite connectivity alternative.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is experiencing significant volatility following its latest earnings report, where strong revenue and data center growth were overshadowed by elevated market expectations and a notable jump in capital expenditures. Community members are actively debating whether this pullback represents a healthy buying opportunity in a multi-year AI infrastructure cycle or a sign that the stock's valuation has become disconnected from its near-term earnings potential.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigen is trending following a strong quarterly earnings report that revealed significant revenue growth, a milestone shift toward operational cash flow break-even, and an optimistic outlook driven by accelerating demand for its FDA-approved therapy, PAPZIMEOS. Community discussion is heavily focused on the stock's high short interest and potential for a squeeze, with investors debating whether the company's commercial execution and upcoming clinical milestones justify a re-rating of its long-term valuation.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust (SLV) is seeing heightened trading volume and volatility as investors weigh conflicting macroeconomic signals, including potential U.S. dollar devaluation, shifting Fed rate expectations, and persistent geopolitical tensions in the Middle East. Community members are actively debating whether the metal is currently building a durable base for a long-term rally or if recent price action remains a vulnerable bull trap fueled by industrial demand narratives and AI-related speculation.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors weigh an aggressive lawsuit against competitor Eli Lilly over alleged misleading advertising practices against the backdrop of an ongoing battle for GLP-1 market dominance. The community remains deeply divided, with many debating the impact of the legal action while others fixate on upcoming earnings, potential manufacturing scale advantages, and the long-term outlook for oral GLP-1 therapies.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending as investors debate the impact of a recent $1 billion credit facility and anticipate upcoming earnings, with the community split between concerns over short-term price manipulation and long-term optimism regarding the firm's AI-driven growth strategy.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is seeing heightened investor attention as market analysts pivot to its AI-driven ad platform, Vector, while the community intensely debates its competitive positioning against AppLovin. Traders are actively tracking large long-dated options positions and potential consolidation patterns, as sentiments split between confidence in a long-term turnaround and frustration over the stock's recent volatility.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is currently drawing significant community attention as investors debate its long-term potential in metal additive manufacturing, particularly regarding its strategic importance to the aerospace and defense sectors. While some discuss the stock's high volatility and short-interest dynamics, others are focused on its newly expanded production capacity and potential role in mission-critical manufacturing supply chains.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXTI is trending following a massive earnings beat and guidance raise, with investors focused on its critical role as a supplier of indium phosphide substrates for AI-driven optical networking. While the community is debating whether the stock's volatility and valuation are justified, bullish sentiment remains centered on the company's multi-year supply agreements with major industry players.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH).  In April 2009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. Or the production of Soliris.

Alexion Pharmaceuticals Inc.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$182.50
Prev Close	$179.45
Open	$181.04
Dividend Yield	N/A
50-Day Moving Average	$179.76
Beta	0.83
Avg. Volume	1.83M
PE Ratio	59.70

52-Week High	$187.45
52-Week Low	$99.91
Market Capitalization	$40.34B
EPS (Annual)	N/A
Price to Book	3.25
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info